Home

cap trial

Capricor Therapeutics Announces Continuation of Phase 3 HOPE-3 Trial - CureDuchenne
Capricor Therapeutics Announces Continuation of Phase 3 HOPE-3 Trial - CureDuchenne

REMAP-CAP • Coronavirus
REMAP-CAP • Coronavirus

DVIDS - Images - Crew chief safety "bump cap" trial [Image 2 of 8]
DVIDS - Images - Crew chief safety "bump cap" trial [Image 2 of 8]

Anti-Thrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia (ATTACC-CAP ) | Trial or Study
Anti-Thrombotic Therapy to Ameliorate Clinical Complications in Community Acquired Pneumonia (ATTACC-CAP ) | Trial or Study

How long should we treat children with pneumonia for? - the results of CAP-IT - Don't Forget the Bubbles
How long should we treat children with pneumonia for? - the results of CAP-IT - Don't Forget the Bubbles

REMAP-CAP and Why we need Platform Trials in a Pandemic - YouTube
REMAP-CAP and Why we need Platform Trials in a Pandemic - YouTube

March: Prostate cap trial | News and features | University of Bristol
March: Prostate cap trial | News and features | University of Bristol

May 15, 2020: Optimized Learning While Doing: The REMAP-CAP Adaptive Platform Trial (Derek Angus, MD, MPH) - Rethinking Clinical Trials
May 15, 2020: Optimized Learning While Doing: The REMAP-CAP Adaptive Platform Trial (Derek Angus, MD, MPH) - Rethinking Clinical Trials

How long should we treat children with pneumonia for? - the results of CAP-IT - Don't Forget the Bubbles
How long should we treat children with pneumonia for? - the results of CAP-IT - Don't Forget the Bubbles

NIH ACTIV Therapeutics Clinical Trials: Host Tissue-Directed Therapeutics
NIH ACTIV Therapeutics Clinical Trials: Host Tissue-Directed Therapeutics

The CAP-IT Trial: Amoxicillin Dose and Duration in Children with Community-Acquired Pneumonia - REBEL EM - Emergency Medicine Blog
The CAP-IT Trial: Amoxicillin Dose and Duration in Children with Community-Acquired Pneumonia - REBEL EM - Emergency Medicine Blog

Seven- to eight-year follow-up of the CoolCap trial of head cooling for neonatal encephalopathy | Pediatric Research
Seven- to eight-year follow-up of the CoolCap trial of head cooling for neonatal encephalopathy | Pediatric Research

Changing Perceptions of Phase 1 Cancer Clinical Trials - NCI
Changing Perceptions of Phase 1 Cancer Clinical Trials - NCI

Thin-Cap Fibroatheroma Rather Than Any Lipid Plaques Increases the Risk of Cardiovascular Events in Diabetic Patients: Insights From the COMBINE OCT–FFR Trial | Circulation: Cardiovascular Interventions
Thin-Cap Fibroatheroma Rather Than Any Lipid Plaques Increases the Risk of Cardiovascular Events in Diabetic Patients: Insights From the COMBINE OCT–FFR Trial | Circulation: Cardiovascular Interventions

HOPE-3 trial of DMD therapy CAP-1002 to continue as planned
HOPE-3 trial of DMD therapy CAP-1002 to continue as planned

CAP trial design. *Further n = 1451 excluded due to prostate cancer... | Download Scientific Diagram
CAP trial design. *Further n = 1451 excluded due to prostate cancer... | Download Scientific Diagram

Presentations — ATTACC-CAP
Presentations — ATTACC-CAP

The SCOUT–CAP Trial: 5d Abx vs. 10d Abx in Pediatric CAP - REBEL EM - Emergency Medicine Blog
The SCOUT–CAP Trial: 5d Abx vs. 10d Abx in Pediatric CAP - REBEL EM - Emergency Medicine Blog

REMAP-CAP Trial
REMAP-CAP Trial

ASCOT and REMAP-CAP awarded nearly $4 million to combine platforms to – ASCOT: The Australasian COVID-19 Trial
ASCOT and REMAP-CAP awarded nearly $4 million to combine platforms to – ASCOT: The Australasian COVID-19 Trial

Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial - The Lancet Oncology
Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial - The Lancet Oncology

REMAP-CAP – The Bottom Line
REMAP-CAP – The Bottom Line